Download PDF
Thromb Haemost 2002; 87(05): 923-924
DOI: 10.1055/s-0037-1613106
Letters to the Editor
Schattauer GmbH

Factor V Arg2074Cys: A Novel Missense Mutation in the C2 Domain of Factor V

Anna Bossone
1   Unita’ di Aterosclerosi e Trombosi, I.R.C.C.S. “Casa Sollievo della Sofferenza”, S. Giovanni Rotondo, Italy
,
Francesca D’Angelo
1   Unita’ di Aterosclerosi e Trombosi, I.R.C.C.S. “Casa Sollievo della Sofferenza”, S. Giovanni Rotondo, Italy
,
Rosa Santacroce
1   Unita’ di Aterosclerosi e Trombosi, I.R.C.C.S. “Casa Sollievo della Sofferenza”, S. Giovanni Rotondo, Italy
,
Domenico De Lucia
2   Istituto di Patologia Generale e Oncologia, Seconda Università di Napoli, Italy
,
Maurizio Margaglione
3   Genetica Medica, Università di Foggia, Italy
› Author Affiliations
Further Information

Publication History

Received 28 December 2001

Accepted after resubmission 28 January 2002

Publication Date:
11 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Van Wijk R, Nieuwenhuis K, van den Berg M, Huizinga EG, van der Meijden BB, Kraaijenhagen RJ, van Solinge WW. Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency. Blood 2001; 98: 358-67.
    CrossrefPubMedGoogle Scholar
  • 2 Margaglione M, Santacroce R, Colaizzo D, Seripa D, Vecchione G, Lupone MR, De Lucia D, Fortina P, Grandone E, Perricone C, Di Minno G. A G-to-A mutation in ivs-3 of the human gamma fibrinogen gene causing afibrinogenemia due to abnormal rna splicing. Blood 2000; 96: 2501-5.
    PubMedGoogle Scholar
  • 3 Ortel TL, Devore-Carter D, Quin-Allen MA, Kane WH. Deletion analysis of recombinant human factor V Evidence for a phosphatydilserine binding site in the second C-type domain. J Biol Chem 1992; 267: 4189-98.
    PubMedGoogle Scholar
  • 4 Kim SW, Quin-Allen MA, Camp JT, Macedo-Ribeiro S, Fuentes-Prior P, Bode W, Kane WH. Identification of functionally important amino acid residues within the C2-domain of human factor V using alanine-scanning mutagenesis. Biochemistry 2000; 39: 1951-8.
    CrossrefPubMedGoogle Scholar
  • 5 Macedo-Ribeiro S, Bode W, Huber R, Quin-Allen MA, Kim SW, Ortel TL, Bourenkov GP, Bartunik HD, Stubbs MT, Kane WH, Fuentes-Prior P. Crystal structures of the membrane-binding C2 domain of human coagulation factor V. Nature 1999; 402: 434-9.
    CrossrefPubMedGoogle Scholar
  • 6 Kemball-Cook G, Tuddenham EG. The Factor VIII Mutation Database on the World Wide Web: the haemophilia A mutation, search, test and resource site HAMSTeRS update (version 3.0). Nucleic Acid Res 1997; 25: 128-32.
    CrossrefPubMedGoogle Scholar
  • 7 Schrijver I, Houissa-Kastally R, Jones CD, Zehnder JL. Identification of a novel factor V C2 domain mutation (R2074H) in two separate families with factor V deficiency and bleeding [abstract]. Blood 2000; 96: 533a.
    PubMedGoogle Scholar
  • 8 Xue J, Kafalatis M, Mann KG. Determination of the disulfide bridges in factor Valight chain. Biochemistry 1993; 32: 5917-23.
    CrossrefPubMedGoogle Scholar
  • 9 Koopman J, Haverkate F, Grimbergen J, Egbring R, Lord ST. Fibrinogen Marburg: a homozygous case of dysfibrinogenemia, lacking amino acids Acx 461-610 (Lys 461 AAA-> stop TAA). Blood 1992; 80: 1972-9.
    PubMedGoogle Scholar
  • 10 Furlan M, Steinmann C, Jungo M. et al. A frameshift mutation in exon V of the Acx-chain gene leading to truncated Acx-chains in the homozygous dysfibrinogen Milano III. J Biol Chem 1994; 269: 33129-34.
    PubMedGoogle Scholar
  • 11 Collen A, Maas A, Kooistra T. et al. Aberrant fibrin formation and crosslinking of fibrinogen Nieuwegein, a variant with a shortened Acx-chain, alters endothelial capillary tube formation. Blood 2001; 97: 973-80.
    CrossrefPubMedGoogle Scholar